Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltrating Lymphocytes”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Very early researchLooking for participantsNCT04943913
What this trial is testing

Study of GC101 TIL in Brain Glioma (Soochow2)

Who this might be right for
Glioma
Shanghai Juncell Therapeutics 50
Not applicableLooking for participantsNCT06453057
What this trial is testing

Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours

Who this might be right for
Adult
Grit Biotechnology 18
Testing effectiveness (Phase 2)Study completedNCT02414945
What this trial is testing

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Who this might be right for
Pleural Mesothelioma
University Health Network, Toronto 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+7 more
Udai Kammula 20
Early research (Phase 1)Looking for participantsNCT05681780
What this trial is testing

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Who this might be right for
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerRecurrent Non Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableNot Yet RecruitingNCT07028008
What this trial is testing

Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors

Who this might be right for
Melanoma
Samsung Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT04260529
What this trial is testing

CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations

Who this might be right for
Advanced Solid Tumor Malignancy
Cytovation AS 60
Very early researchNot Yet RecruitingNCT07498595
What this trial is testing

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Early research (Phase 1)Active Not RecruitingNCT05902520
What this trial is testing

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Who this might be right for
HNSCCMelanomaGynecologic Cancer+3 more
AgonOx, Inc. 18
Early research (Phase 1)UnknownNCT04443296
What this trial is testing

Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Sun Yat-sen University 10
Not applicableStudy completedNCT05610592
What this trial is testing

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Who this might be right for
Tumor BuddingRectal Cancer
Sun Yat-sen University 480
Not applicableEnded earlyNCT06191900
What this trial is testing

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

Who this might be right for
AdultGynecological Tumors
Grit Biotechnology 4
Testing effectiveness (Phase 2)Looking for participantsNCT04114136
What this trial is testing

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Who this might be right for
MelanomaNSCLCHepatocellular Carcinoma+5 more
Dan Zandberg 72
Testing effectiveness (Phase 2)Looking for participantsNCT06538012
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more
Essen Biotech 85
Very early researchNot Yet RecruitingNCT07498439
What this trial is testing

TILs Therapy for Multiple Primary Early-Stage NSCLC

Who this might be right for
Primary Early-stage Non-small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Not applicableLooking for participantsNCT06470607
What this trial is testing

The Lymphocytic Infiltrate of Lung Tumors.

Who this might be right for
Lung CancerImmune System
Scientific Institute San Raffaele 70
Testing effectiveness (Phase 2)Study completedNCT01993719
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
National Cancer Institute (NCI) 33
Early research (Phase 1)Active Not RecruitingNCT05869539
What this trial is testing

ACT-TIL and ANV419 for Advanced Melanoma.

Who this might be right for
Advanced Melanoma
University Hospital, Basel, Switzerland 10
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Testing effectiveness (Phase 2)Ended earlyNCT05050006
What this trial is testing

ITIL-168 in Advanced Melanoma

Who this might be right for
Advanced Cutaneous Melanoma
Instil Bio 29
Load More Results